212 related articles for article (PubMed ID: 32197982)
1. Molecular dynamics study on the encapsulation and release of anti-cancer drug doxorubicin by chitosan.
Li J; Ying S; Ren H; Dai J; Zhang L; Liang L; Wang Q; Shen Q; Shen JW
Int J Pharm; 2020 Apr; 580():119241. PubMed ID: 32197982
[TBL] [Abstract][Full Text] [Related]
2. Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations.
Karnati KR; Wang Y
Phys Chem Chem Phys; 2018 Apr; 20(14):9389-9400. PubMed ID: 29565091
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics study on the adsorption and release of doxorubicin by chitosan-decorated graphene.
Shen JW; Li J; Dai J; Zhou M; Ren H; Zhang L; Hu Q; Kong Z; Liang L
Carbohydr Polym; 2020 Nov; 248():116809. PubMed ID: 32919542
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
[TBL] [Abstract][Full Text] [Related]
5. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
7. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Al-Husein BA
Curr Cancer Drug Targets; 2022; 22(2):133-141. PubMed ID: 35081892
[TBL] [Abstract][Full Text] [Related]
8. pH-controlled doxorubicin anticancer loading and release from carbon nanotube noncovalently modified by chitosan: MD simulations.
Rungnim C; Rungrotmongkol T; Poo-Arporn RP
J Mol Graph Model; 2016 Nov; 70():70-76. PubMed ID: 27677150
[TBL] [Abstract][Full Text] [Related]
9. Design and Development of Graphene Oxide Nanoparticle/Chitosan Hybrids Showing pH-Sensitive Surface Charge-Reversible Ability for Efficient Intracellular Doxorubicin Delivery.
Zhao X; Wei Z; Zhao Z; Miao Y; Qiu Y; Yang W; Jia X; Liu Z; Hou H
ACS Appl Mater Interfaces; 2018 Feb; 10(7):6608-6617. PubMed ID: 29368916
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
Hu FQ; Liu LN; Du YZ; Yuan H
Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of antitumor drug Doxorubicin and its analogue by chitosan nanoparticles.
Sanyakamdhorn S; Agudelo D; Tajmir-Riahi HA
Biomacromolecules; 2013 Feb; 14(2):557-63. PubMed ID: 23305154
[TBL] [Abstract][Full Text] [Related]
12. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
13. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform.
Bothiraja C; Rajput N; Poudel I; Rajalakshmi S; Panda B; Pawar A
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):447-461. PubMed ID: 29368543
[TBL] [Abstract][Full Text] [Related]
14. Simply constructed chitosan nanocarriers with precise spatiotemporal control for efficient intracellular drug delivery.
Kong M; Zuo Y; Wang M; Bai X; Feng C; Chen X
Carbohydr Polym; 2017 Aug; 169():341-350. PubMed ID: 28504154
[TBL] [Abstract][Full Text] [Related]
15. Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations.
Yousefpour P; Atyabi F; Farahani EV; Sakhtianchi R; Dinarvand R
Int J Nanomedicine; 2011; 6():1487-96. PubMed ID: 21796249
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
[TBL] [Abstract][Full Text] [Related]
17. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
[TBL] [Abstract][Full Text] [Related]
18. Molecular Dynamics Simulations of the pH-Dependent Adsorption of Doxorubicin on Carbon Quantum Dots.
Wolski P
Mol Pharm; 2021 Jan; 18(1):257-266. PubMed ID: 33325232
[TBL] [Abstract][Full Text] [Related]
19. A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.
Chen C; Zhou JL; Han X; Song F; Wang XL; Wang YZ
Nanotechnology; 2014 Jun; 25(25):255101. PubMed ID: 24896540
[TBL] [Abstract][Full Text] [Related]
20. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
